Anticoagulant effects of the selective factor Xa inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition
- 15 December 1991
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 64 (6), 787-794
- https://doi.org/10.1016/0049-3848(91)90081-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Low Molecular Weight Heparins and BleedingSeminars in Thrombosis and Hemostasis, 1989
- Heparin therapy for venous thrombosis and pulmonary embolismBlood Reviews, 1988
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- The effect of heparin fragments of different molecular weights on experimental thrombosis and haemostasisThrombosis Research, 1985
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbitsBlood, 1982
- Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbitsThrombosis Research, 1982
- Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous ThrombosisNew England Journal of Medicine, 1982
- Management of Heparin TherapyNew England Journal of Medicine, 1975
- A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin TimeNew England Journal of Medicine, 1972
- ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISMThe Lancet, 1960